Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Home on the range where the buffalo roam -- Ignore unavailable to you. Want to Upgrade?

To: DOUG H who wrote (3366)	8/20/2001 7:56:42 PM
From: Walkingshadow	Read Replies (2) \| Respond to of 13815

Here's another for the LTB..... askresearch.com 1. Competition: zero 2. Barrier to entry: Virtually insurmountable, without entirely new technology being invented/patented/developed, which would certainly require enormous expenditure and a decade. At least. 3. Potential demand: huge; 90% of those needing transplants do not get them because of limited supply of donors. 4. Alternative 'treatment': death. Soon. For sure. 5. FDA approval probability: considering 3 & 4, fast track 'look the other way if there's any problems' approval assured. Now in human clinicals. .... and, FWIW, buy signals virtually across the board, but note the average daily volume is low, so TA not that reliable here, as you know. Still, successfully tested chart support, with a bullish engulfing formation Fri/today. I think this one is a stock that, if you don't accumulate it now for the LTB, a year or maybe two from now you'll really, really regret it. T